Donald L. Hagan, LLC Lian Bio Transaction History

Donald L. Hagan, LLC

  • $183 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024
BUY
$1.33 - $4.6 $7,448 - $25,759
5,600 Added 37.33%
20,600 $92,000
Q2 2023

Jul 17, 2023
BUY
$1.79 - $2.85 $26,850 - $42,750
15,000 New
15,000 $34,000

Others Institutions Holding LIAN

# of Institutions
3
Shares Held
1.1M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Donald L. Hagan, LLC Portfolio

Follow Donald L. Hagan, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Donald L. Hagan, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Donald L. Hagan, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email